Pfizer Tumbles After Abandoning Weight-Loss Pill
December 02, 2023 at 16:40 PM EST
With shares already reflecting a post-COVID dearth of revenue streams, Pfizer's growth outlook recently took another hit as it halted development of its experimental weight-loss pill after a high rate of side effects appeared in a mid-stage study.
